Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




20-Minute POC Test to Diagnose STIs from Rectal and Throat Swabs

By LabMedica International staff writers
Posted on 09 Jun 2023

Every day, over a million new cases of sexually transmitted infections (STIs) are identified across the globe, making diseases such as gonorrhea and Chlamydia significant health concerns. More...

Although Chlamydia is the most frequently diagnosed STI, gonorrhea cases have also been on the rise. The World Health Organization (WHO) has reported a swift increase in multi-drug resistant gonorrhea, with almost all confirmed treatment failures linked to pharyngeal infections, impacting the throat. Traditional tests involve identifying DNA from swabs or urine samples, which require lab processing and could result in delays from several days to weeks between testing and result delivery. The extraction of DNA from rectal or pharyngeal swabs, however, presents more difficulties Now, a new testing platform technology is being optimized and validated to diagnose STIs from rectal and pharyngeal (throat) swabs.

Linear Diagnostics (Birmingham, UK), a University of Birmingham (Birmingham, UK) spinout, has received funding from the National Institute for Health and Care Research (NIHR, London, UK) to optimize and validate its LDx-CTNG platform technology. This innovative approach utilizes linear dichroism, where a beam of polarized light detects multiple targets from a single sample. The process works by detecting a shift in the plane of polarized light when a target is bound to a detector. Various molecular recognition methods can be used on the detector molecules to measure the target analytes of interest, such as using antibodies to detect antigens or oligonucleotides to capture corresponding target DNA sequences.

Linear Diagnostics' linear dichroism detection technology can identify short, rapidly synthesized DNA strands, enabling the utilization of EXPAR, an ultrafast DNA amplification method. This has drastically reduced the result delivery time compared to traditional PCR and simplified the necessary hardware due to the isothermal nature of EXPAR, which does not require complex heating and cooling cycles. The incorporation of dyes for multiplexing that absorb in the visible light spectrum has facilitated the use of affordable optical components, enabling the device to be miniaturized to a fully portable size. Moreover, the system can be operated using an internal rechargeable battery, eliminating dependence on main power sources or computer access. By pairing linear dichroism with a disposable cartridge and instrument, it is possible to perform simple point-of-care testing. A proof-of-concept study has already indicated that this technology can provide rapid and accurate diagnostic testing.

“For STIs, the rapidity of the testing procedure is key, as patients prefer to get test results quickly and start treatment immediately,” said Brendan Farrell, Chairman of Linear Diagnostics. “We are aiming to produce a testing platform that will meet the WHO stipulations of being easy to use with minimal training, so people can present for testing and collect their treatment in a single visit.”

Related Links:
Linear Diagnostics 
University of Birmingham 
NIHR 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.